Matches in Nanopublications for { ?s ?p "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP134196.RAQg5crw38esUyU52SdmsjGJQS8EKPIe8oGONhJPKCa4g130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134196.RAQg5crw38esUyU52SdmsjGJQS8EKPIe8oGONhJPKCa4g130_provenance.
- NP134312.RAfLZMgl4Nz12Gd40ebIwKbKXQOMz3y14OEIvjr1cPXOw130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134312.RAfLZMgl4Nz12Gd40ebIwKbKXQOMz3y14OEIvjr1cPXOw130_provenance.
- NP134269.RAn0pe-GiAiu1mU_odasiBM1wEWkvPV4UrNv3C0q74F_E130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134269.RAn0pe-GiAiu1mU_odasiBM1wEWkvPV4UrNv3C0q74F_E130_provenance.
- NP134112.RAyBvNSpCvNgijr4mjlxJZX718_95vk0N7LjBpIs5_eU0130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134112.RAyBvNSpCvNgijr4mjlxJZX718_95vk0N7LjBpIs5_eU0130_provenance.
- NP134309.RAy-X8S0yw_Q4S9SgknBwEJd8fKKgg8FIWiXYu_OkGGoc130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134309.RAy-X8S0yw_Q4S9SgknBwEJd8fKKgg8FIWiXYu_OkGGoc130_provenance.
- NP197269.RAhzNqSsjLR1scqcNkWOjU4-HcaooM_aidzAoL6SWSRzc130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197269.RAhzNqSsjLR1scqcNkWOjU4-HcaooM_aidzAoL6SWSRzc130_provenance.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_provenance.
- NP197426.RABxvcGGo_fbX71alGlxNdBeK3Rjj6hz4CRn0of8QIOPI130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197426.RABxvcGGo_fbX71alGlxNdBeK3Rjj6hz4CRn0of8QIOPI130_provenance.
- NP223256.RArqM4rYb8RhRDmnskJfJEgr7s1F0HRwVeUYQpQn9s5UM130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223256.RArqM4rYb8RhRDmnskJfJEgr7s1F0HRwVeUYQpQn9s5UM130_provenance.
- NP223253.RAI-Dgl8jbLzT_1TXd70VckZRk_A1JIR2A-PuijylYfHY130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223253.RAI-Dgl8jbLzT_1TXd70VckZRk_A1JIR2A-PuijylYfHY130_provenance.
- NP223258.RAJ5gxYscKyeXNsEUlZ_gLXamHf7o0bY3ntEZF1jh8lFo130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223258.RAJ5gxYscKyeXNsEUlZ_gLXamHf7o0bY3ntEZF1jh8lFo130_provenance.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_provenance.